NDC 63187-705

Trezix

Acetaminophen, Caffeine, Dihydrocodeine Bitartrate

Trezix is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Proficient Rx Lp. The primary component is Acetaminophen; Caffeine; Dihydrocodeine Bitartrate.

Product ID63187-705_7cbe39b8-ce3c-4064-a763-36158070cebd
NDC63187-705
Product TypeHuman Prescription Drug
Proprietary NameTrezix
Generic NameAcetaminophen, Caffeine, Dihydrocodeine Bitartrate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2014-12-01
Marketing CategoryANDA / ANDA
Application NumberANDA204785
Labeler NameProficient Rx LP
Substance NameACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
Active Ingredient Strength321 mg/1; mg/1; mg/1
Pharm ClassesCentral Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE],Full Opioid Agonists [MoA],Opioid Agonist [EPC]
DEA ScheduleCIII
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 63187-705-00

100 CAPSULE in 1 BOTTLE (63187-705-00)
Marketing Start Date2016-06-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63187-705-30 [63187070530]

Trezix CAPSULE
Marketing CategoryANDA
Application NumberANDA204785
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-06-01

NDC 63187-705-60 [63187070560]

Trezix CAPSULE
Marketing CategoryANDA
Application NumberANDA204785
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-06-01

NDC 63187-705-90 [63187070590]

Trezix CAPSULE
Marketing CategoryANDA
Application NumberANDA204785
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-06-01

NDC 63187-705-72 [63187070572]

Trezix CAPSULE
Marketing CategoryANDA
Application NumberANDA204785
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-08-01

NDC 63187-705-00 [63187070500]

Trezix CAPSULE
Marketing CategoryANDA
Application NumberANDA204785
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-06-01

Drug Details

Active Ingredients

IngredientStrength
ACETAMINOPHEN320.5 mg/1

OpenFDA Data

SPL SET ID:45c3c2a1-6a89-471e-b6d4-5a4cd73b987a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1190201
  • 1596108

    • Pharmacological Class

    • Central Nervous System Stimulant [EPC]
    • Methylxanthine [EPC]
    • Xanthines [CS]
    • Central Nervous System Stimulation [PE]
    • Full Opioid Agonists [MoA]
    • Opioid Agonist [EPC]

    NDC Crossover Matching brand name "Trezix" or generic name "Acetaminophen, Caffeine, Dihydrocodeine Bitartrate"

    NDCBrand NameGeneric Name
    63187-705Trezixacetaminophen, caffeine, dihydrocodeine bitartrate
    63629-5637Trezixacetaminophen, caffeine, dihydrocodeine bitartrate
    66992-340Trezixacetaminophen, caffeine, dihydrocodeine bitartrate
    66992-840Trezixacetaminophen, caffeine, dihydrocodeine bitartrate
    42195-840Acetaminophen, Caffeine, Dihydrocodeine BitartrateAcetaminophen, Caffeine, Dihydrocodeine Bitartrate

    Trademark Results [Trezix]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TREZIX
    TREZIX
    88326471 not registered Live/Pending
    Wraser Pharmaceuticals
    2019-03-05
    TREZIX
    TREZIX
    86660330 4889095 Live/Registered
    Wraser Pharmaceuticals
    2015-06-12
    TREZIX
    TREZIX
    77101832 3463260 Dead/Cancelled
    E5 Pharma, Inc.
    2007-02-07
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.